102 related articles for article (PubMed ID: 21129256)
1. [Effects of xbp-1 gene silencing on bortezomib-induced apoptosis in human multiple myeloma cells].
Yang Y; Dong HJ; Gao GX; Wang YW; Gu HT; Shu MM; Zhu HF; Chen XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1177-80. PubMed ID: 21129256
[TBL] [Abstract][Full Text] [Related]
2. [Effects of triptolide on bortezomib-induced apoptosis in multiple myeloma cells].
Yang Y; Dong HJ; Gao GX; Wang YW; Gu HT; Chen XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):335-8. PubMed ID: 22541093
[TBL] [Abstract][Full Text] [Related]
3. [Bortezomib-induced BiP expression and apoptosis in multiple myeloma cells].
Dong HJ; Chen XQ; Gao GX; Gu HT; Pan YZ; Gao Y; Zhu HF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):107-10. PubMed ID: 19236758
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells.
Dong H; Chen L; Chen X; Gu H; Gao G; Gao Y; Dong B
Leuk Lymphoma; 2009 Jun; 50(6):974-84. PubMed ID: 19391038
[TBL] [Abstract][Full Text] [Related]
5. [Study on the relationship of beta-catenin level and sensitivity to Bortezomib of myeloma cell lines].
Zhou LL; Fu WJ; Yuan ZG; Wang DX; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):234-7. PubMed ID: 18843976
[TBL] [Abstract][Full Text] [Related]
6. Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1.
Ling SC; Lau EK; Al-Shabeeb A; Nikolic A; Catalano A; Iland H; Horvath N; Ho PJ; Harrison S; Fleming S; Joshua DE; Allen JD
Haematologica; 2012 Jan; 97(1):64-72. PubMed ID: 21993678
[TBL] [Abstract][Full Text] [Related]
7. [Effect of curcumin in combination with bortezomib on proliferation and apoptosis of human multiple myeloma cell line H929 and its mechanism].
Zhang XY; Bai QX; Huang GS; Zhao H; Chen JJ; Yang LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):684-8. PubMed ID: 21729550
[TBL] [Abstract][Full Text] [Related]
8. Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines.
de Carvalho F; Costa ET; Camargo AA; Gregorio JC; Masotti C; Andrade VC; Strauss BE; Caballero OL; Atanackovic D; Colleoni GW
PLoS One; 2011; 6(11):e27707. PubMed ID: 22110734
[TBL] [Abstract][Full Text] [Related]
9. [Effect of arsenic trioxide combined with bortezomib on proliferation, apoptosis and beta-catenin level in myeloma cell lines].
Zhou LL; Fu WJ; Yuan ZG; Wang DX; Hou J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):84-8. PubMed ID: 18315906
[TBL] [Abstract][Full Text] [Related]
10. Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells.
Wada N; Kawano Y; Fujiwara S; Kikukawa Y; Okuno Y; Tasaki M; Ueda M; Ando Y; Yoshinaga K; Ri M; Iida S; Nakashima T; Shiotsu Y; Mitsuya H; Hata H
Int J Oncol; 2015 Mar; 46(3):963-72. PubMed ID: 25530098
[TBL] [Abstract][Full Text] [Related]
11. Reduced response of IRE1α/Xbp-1 signaling pathway to bortezomib contributes to drug resistance in multiple myeloma cells.
Xu X; Liu J; Huang B; Chen M; Yuan S; Li X; Li J
Tumori; 2017 May; 103(3):261-267. PubMed ID: 27647225
[TBL] [Abstract][Full Text] [Related]
12. Caspase-2 functions upstream of mitochondria in endoplasmic reticulum stress-induced apoptosis by bortezomib in human myeloma cells.
Gu H; Chen X; Gao G; Dong H
Mol Cancer Ther; 2008 Aug; 7(8):2298-307. PubMed ID: 18723477
[TBL] [Abstract][Full Text] [Related]
13. Differentiation induction enhances bortezomib efficacy and overcomes drug resistance in multiple myeloma.
Gu JL; Li J; Zhou ZH; Liu JR; Huang BH; Zheng D; Su C
Biochem Biophys Res Commun; 2012 Apr; 420(3):644-50. PubMed ID: 22450313
[TBL] [Abstract][Full Text] [Related]
14. Effects of arsenic trioxide combined with bortezomib on apoptosis of multiple myeloma cell line KM3 and its mechanisms.
Ge QF; Ouyang GF; Chen Y; Zhang Y; Mu QT; Lu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):112-5. PubMed ID: 22391178
[TBL] [Abstract][Full Text] [Related]
15. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response.
Nowis D; McConnell EJ; Dierlam L; Palamarchuk A; Lass A; Wójcik C
Int J Cancer; 2007 Jul; 121(2):431-41. PubMed ID: 17373661
[TBL] [Abstract][Full Text] [Related]
16. [Bortezomib depresses osteoblast apoptosis induced by mouse myeloma cells].
Zhao H; Bai QX; Huang GS; Yang LJ; Yue P; Zhang XY; Wang L; Fan LN; Zhu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1186-91. PubMed ID: 21129258
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanism of myeloma cell line differentiation induced by 2-methoxyestradiol].
Gao WR; Hou J; Xiong H
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):598-601. PubMed ID: 16532968
[TBL] [Abstract][Full Text] [Related]
18. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
[TBL] [Abstract][Full Text] [Related]
19. Requirement of apoptotic protease-activating factor-1 for bortezomib-induced apoptosis but not for Fas-mediated apoptosis in human leukemic cells.
Ottosson-Wadlund A; Ceder R; Preta G; Pokrovskaja K; Grafström RC; Heyman M; Söderhäll S; Grandér D; Hedenfalk I; Robertson JD; Fadeel B
Mol Pharmacol; 2013 Jan; 83(1):245-55. PubMed ID: 23093495
[TBL] [Abstract][Full Text] [Related]
20. ShRNA-mediated Bmi-1 silencing sensitizes multiple myeloma cells to bortezomib.
Wu SQ; Xu ZZ; Niu WY; Huang HB; Zhan R
Int J Mol Med; 2014 Aug; 34(2):616-23. PubMed ID: 24913180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
